Risk of preterm delivery and other adverse perinatal outcomes in relation to maternal use of psychotropic medications during pregnancy

American Journal of Obstetrics and Gynecology

Volumn 201, Issue 6, 2009, Pages 579.e1-579.e8

  Calderon Margalit, Ronit ^a,b   Qiu, Chunfang ^d   Ornoy, Asher ^e   Siscovick, David S ^a,b,c   Williams, Michelle A ^b,d  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d SWEDISH MEDICAL CENTER   (United States)

^e HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

benzodiazepine; cohort; pregnancy; preterm birth; selective serotonin reuptake inhibitor (SSRI)

Indexed keywords

ALPRAZOLAM; AMFEBUTAMONE; BENZODIAZEPINE; BUSPIRONE; CARBAMAZEPINE; CITALOPRAM; CLONAZEPAM; DIAZEPAM; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; GABAPENTIN; HYDROXYZINE; LITHIUM; LORAZEPAM; NEFAZODONE; NORTRIPTYLINE; OLANZAPINE; PAROXETINE; PROPRANOLOL; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADULT; ARTICLE; COHORT ANALYSIS; DRUG USE; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; LOGISTIC REGRESSION ANALYSIS; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; NEWBORN DISEASE; NEWBORN INTENSIVE CARE; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; RISK; RISK ASSESSMENT;

EID: 70949084499     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2009.06.061     Document Type: Article

References (26)

1. Ververs T., Kaasenbrood H., Visser G., Schobben F., de Jong-van den Berg L., and Egberts T. Prevalence and patterns of antidepressant drug use during pregnancy. Eur J Clin Pharmacol 62 (2006) 863-870
2. Ramos E., Oraichi D., Rey E., Blais L., and Berard A. Prevalence and predictors of antidepressant use in a cohort of pregnant women. BJOG 114 (2007) 1055-1064
3. Andrade S.E., Raebel M.A., Brown J., et al. Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol 198 (2008) 194 e1-5
4. Stafford R.S., MacDonald E.A., and Finkelstein S.N. National Patterns of Medication Treatment for Depression, 1987 to 2001. Prim Care Companion J Clin Psychiatry 3 (2001) 232-235
5. Trenkwalder C., Paulus W., and Walters A.S. The restless legs syndrome. Lancet Neurol 4 (2005) 465-475
6. American College of Obstetricians and Gynecologists. Use of psychiatric medications during pregnancy and lactation: ACOG practice bulletin no. 92: clinical management guidelines for obstetrician-gynecologists, April 2008. (replaces practice bulletin no. 87). Obstet Gynecol 111 (2008) 1001-1020
7. McElhatton P.R. The effects of benzodiazepine use during pregnancy and lactation. Reprod Toxicol 8 (1994) 461-475
8. Moses-Kolko E.L., Bogen D., Perel J., et al. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications. JAMA 293 (2005) 2372-2383
9. Ferreira E., Carceller A.M., Agogue C., et al. Effects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonates. Pediatrics 119 (2007) 52-59
10. Goldenberg R.L., Culhane J.F., Iams J.D., and Romero R. Epidemiology and causes of preterm birth. Lancet 371 (2008) 75-84
11. Saigal S., and Doyle L.W. An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet 371 (2008) 261-269
12. Chambers C.D., Johnson K.A., Dick L.M., Felix R.J., and Jones K.L. Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 335 (1996) 1010-1015
13. Kallen B. Neonate characteristics after maternal use of antidepressants in late pregnancy. Arch Pediatr Adolesc Med 158 (2004) 312-316
14. Wikner B.N., Stiller C.O., Bergman U., Asker C., and Kallen B. Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: neonatal outcome and congenital malformations. Pharmacoepidemiol Drug Saf 16 (2007) 1203-1210
15. Ornoy A., Arnon J., Shechtman S., Moerman L., and Lukashova I. Is benzodiazepine use during pregnancy really teratogenic?. Reprod Toxicol 12 (1998) 511-515
16. Lennestal R., and Kallen B. Delivery outcome in relation to maternal use of some recently introduced antidepressants. J Clin Psychopharmacol 27 (2007) 607-613
17. Wen S.W., Yang Q., Garner P., et al. Selective serotonin reuptake inhibitors and adverse pregnancy outcomes. Am J Obstet Gynecol 194 (2006) 961-966
18. Diav-Citrin O., Shechtman S., Weinbaum D., et al. Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study. Br J Clin Pharmacol 66 (2008) 695-705
19. Oberlander T.F., Warburton W., Misri S., Aghajanian J., and Hertzman C. Effects of timing and duration of gestational exposure to serotonin reuptake inhibitor antidepressants: population-based study. Br J Psychiatry 192 (2008) 338-343
20. Simon G.E., Cunningham M.L., and Davis R.L. Outcomes of prenatal antidepressant exposure. Am J Psychiatry 159 (2002) 2055-2061
21. Kallen B.A., and Otterblad Olausson P. Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations. Birth Defects Res A Clin Mol Teratol 79 (2007) 301-308
22. Dayan J., Creveuil C., Herlicoviez M., et al. Role of anxiety and depression in the onset of spontaneous preterm labor. Am J Epidemiol 155 (2002) 293-301
23. Berle J.O., Mykletun A., Daltveit A.K., Rasmussen S., Holsten F., and Dahl A.A. Neonatal outcomes in offspring of women with anxiety and depression during pregnancy: a linkage study from the Nord-Trondelag Health study (HUNT) and Medical Birth Registry of Norway. Arch Womens Ment Health 8 (2005) 181-189
24. Glynn L.M., Schetter C.D., Hobel C.J., and Sandman C.A. Pattern of perceived stress and anxiety in pregnancy predicts preterm birth. Health Psychol 27 (2008) 43-51
25. Macleod J., and Davey Smith G. Psychosocial factors and public health: a suitable case for treatment?. J Epidemiol Community Health 57 (2003) 565-570
26. Neutel C.I., and Patten S.B. Risk of suicide attempts after benzodiazepine and/or antidepressant use. Ann Epidemiol 7 (1997) 568-574